Drug Discovery Informatics Market Size, Share, and Trends 2024 to 2034

Drug Discovery Informatics Market (By Service: Sequence Analysis Platform, Molecular Modeling, Clinical Trial Data Management, Docking; By End-User: Pharmaceutical and Biotechnological Companies, Contract Research Organization (CRO)) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 3782
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug Discovery Informatics Market 

5.1. COVID-19 Landscape: Drug Discovery Informatics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug Discovery Informatics Market, By Service

8.1. Drug Discovery Informatics Market, by Service, 2024-2034

8.1.1. Sequence Analysis Platform

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Molecular Modeling

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Clinical Trial Data Management

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Docking

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Drug Discovery Informatics Market, By End-User

9.1. Drug Discovery Informatics Market, by End-User, 2024-2034

9.1.1. Pharmaceutical and Biotechnological Companies

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Contract Research Organization (CRO)

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Drug Discovery Informatics Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Service (2021-2034)

10.1.2. Market Revenue and Forecast, by End-User (2021-2034)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.1.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.1.4.2. Market Revenue and Forecast, by End-User (2021-2034)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Service (2021-2034)

10.2.2. Market Revenue and Forecast, by End-User (2021-2034)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.2.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.2.4.2. Market Revenue and Forecast, by End-User (2021-2034)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Service (2021-2034)

10.2.5.2. Market Revenue and Forecast, by End-User (2021-2034)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Service (2021-2034)

10.2.6.2. Market Revenue and Forecast, by End-User (2021-2034)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.3.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.3.4.2. Market Revenue and Forecast, by End-User (2021-2034)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Service (2021-2034)

10.3.5.2. Market Revenue and Forecast, by End-User (2021-2034)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Service (2021-2034)

10.3.6.2. Market Revenue and Forecast, by End-User (2021-2034)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.4.2. Market Revenue and Forecast, by End-User (2021-2034)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.4.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.4.4.2. Market Revenue and Forecast, by End-User (2021-2034)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Service (2021-2034)

10.4.5.2. Market Revenue and Forecast, by End-User (2021-2034)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Service (2021-2034)

10.4.6.2. Market Revenue and Forecast, by End-User (2021-2034)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Service (2021-2034)

10.5.2. Market Revenue and Forecast, by End-User (2021-2034)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Service (2021-2034)

10.5.3.2. Market Revenue and Forecast, by End-User (2021-2034)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Service (2021-2034)

10.5.4.2. Market Revenue and Forecast, by End-User (2021-2034)

Chapter 11. Company Profiles

11.1. Collaborative Drug Discovery, Inc. Abbott

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Eurofins DiscoverX Products

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Jubliant Biosys

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Selvita

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Novo Informatics Pvt. Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. ChemAxon Ltd.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Albany Molecular Research Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Certara

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Boehringer Ingelheim International GmbH

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Infosys Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client